Affinity improvement of a therapeutic antibody to methamphetamine and amphetamine through structure-based antibody engineering
about
Fc receptors and their influence on efficacy of therapeutic antibodies for treatment of viral diseasesAntibody H3 Structure Prediction.A tool kit for rapid cloning and expression of recombinant antibodies.Development trends for generation of single-chain antibody fragments.Antibody Derived Peptides for Detection of Ebola Virus Glycoprotein.A Nanotechnology-Based Platform for Extending the Pharmacokinetic and Binding Properties of Anti-methamphetamine Antibody Fragments.Successful engineering of a highly potent single-chain variable-fragment (scFv) bispecific antibody to target disialoganglioside (GD2) positive tumorsSphinx: merging knowledge-based and ab initio approaches to improve protein loop prediction.How B-Cell Receptor Repertoire Sequencing Can Be Enriched with Structural Antibody Data.A mathematical model of a recombinant humanized anti-cocaine monoclonal antibody's effects on cocaine pharmacokinetics in mice.A Highly Sensitive Detection System based on Proximity-dependent Hybridization with Computer-aided Affinity Maturation of a scFv Antibody.PEGylation of a High-Affinity Anti-(+)Methamphetamine Single Chain Antibody Fragment Extends Functional Half-Life by Reducing Clearance.Development and testing of AAV-delivered single-chain variable fragments for the treatment of methamphetamine abuse.
P2860
Q26783175-D6518A77-CDE0-4473-9B85-1CC460582C32Q30398990-8E712AE4-6FD2-4D87-A8C5-58C3F1E4C13BQ33970343-B4E37362-7B62-427A-82F5-AECC81DCF86AQ35216785-C5F53AAD-1C1F-44D7-8F8D-4ECC7D6CAF7AQ35816320-652961B0-7C79-4D16-ABD9-7AAE72E0DD29Q35837611-36B2D90F-2406-4F32-87B9-8FD0F72277CEQ37078941-0B02AEBF-91F1-4DB6-AD7B-6A5242E05BDEQ38814529-B91F9300-9320-456C-AD70-66BB6108769DQ47113886-7901707C-187E-4FCA-A454-70C5015E1010Q47275335-2706F35F-3B6D-4ADA-8668-E2F0A3CFE3C8Q52370095-44C1E379-82A8-4FA2-AB5E-67113F719037Q53891489-CF58C207-190B-4B34-A6EC-6C5E3114654EQ55471442-424FB0E6-B1BB-47F5-9E1F-FEDAC2C48B48
P2860
Affinity improvement of a therapeutic antibody to methamphetamine and amphetamine through structure-based antibody engineering
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Affinity improvement of a ther ...... ure-based antibody engineering
@ast
Affinity improvement of a ther ...... ure-based antibody engineering
@en
Affinity improvement of a ther ...... ure-based antibody engineering
@nl
type
label
Affinity improvement of a ther ...... ure-based antibody engineering
@ast
Affinity improvement of a ther ...... ure-based antibody engineering
@en
Affinity improvement of a ther ...... ure-based antibody engineering
@nl
prefLabel
Affinity improvement of a ther ...... ure-based antibody engineering
@ast
Affinity improvement of a ther ...... ure-based antibody engineering
@en
Affinity improvement of a ther ...... ure-based antibody engineering
@nl
P2093
P2860
P3181
P356
P1433
P1476
Affinity improvement of a ther ...... ure-based antibody engineering
@en
P2093
Eric C Peterson
Nisha Nanaware-Kharade
Reha Celikel
Shraddha Thakkar
P2860
P2888
P3181
P356
10.1038/SREP03673
P407
P577
2014-01-14T00:00:00Z
P5875
P6179
1018933763